Wegovy Injection or Tablet: Which Should I Choose?

# Wegovy Injection or Tablet: Which Should I Choose?

With the approval of the Wegovy tablet by the MHRA in June 2026, people starting semaglutide treatment in the UK now face a choice that did not exist before: injection or tablet?

This guide is for people who have not yet started either, and want to make an informed first decision. It is not about switching between the two — if you are already on one and considering moving to the other, see our dedicated switching guides. This is a decision framework for people starting fresh.

There is no universally right answer. Both products contain the same active ingredient — semaglutide — and both are licensed for weight management in UK adults with a qualifying BMI. The differences are real, meaningful, and worth understanding carefully before committing to a treatment format.

> **Medical disclaimer:** Both the Wegovy injection and the Wegovy tablet are prescription-only medicines. A clinical assessment by a qualified UK healthcare professional is required before either can be prescribed. The information in this guide is for general educational purposes and does not replace the advice of your prescribing clinician.

—

## Start here: what matters most to you?

Rather than declaring a winner, the most useful thing this guide can do is help you identify your own priorities. The two formats are different tools. Which one is right depends on what you need.

—

## Choose the Wegovy tablet if

**You have needle phobia or strong aversion to injections.** This is the single clearest indication for the tablet. If the prospect of a weekly injection is a significant source of anxiety — not mild discomfort, but genuine aversion — you are unlikely to adhere reliably to an injection programme. Consistent adherence to a lower-ceiling treatment is better than inconsistent adherence to a higher-ceiling one.

**You travel frequently.** The Wegovy injection must be refrigerated (2–8°C), stored in carry-on luggage (not the hold), declared at some airports, and disposed of in sharps bins at your destination. None of these requirements apply to the tablet. If you are regularly on flights for work or leisure, this difference is significant.

**The monthly cost matters.** The Wegovy tablet starts from £64 per month from UK providers. The Wegovy injection typically costs £149–£269 per month privately. If you are self-funding treatment over 12–18 months, the tablet can be thousands of pounds cheaper. Treatment you can afford to continue is better than treatment you stop due to cost.

**You can commit to a daily morning routine.** The tablet requires taking it on waking with only 120ml of plain still water, then waiting at least 30 minutes before eating or drinking anything else. If this fits naturally with how you already start your day — or if you are willing to adjust — the daily routine is manageable.

**You are just starting out.** If you have no prior experience with semaglutide or any GLP-1 treatment, starting with the tablet is a completely valid choice. You are not missing out on something more effective if you choose the tablet — you are choosing a different format of the same drug, with a different lifestyle fit and a somewhat different effectiveness profile.

—

## Choose the Wegovy injection if

**Maximum weight loss is your primary goal.** Clinical trial data is consistent: the Wegovy injection (STEP trials, ~20.7% average weight loss at maximum dose) outperforms the Wegovy tablet (OASIS trials, ~14–16% at maximum dose) on the primary outcome of total weight lost. If you have a significant amount of weight to lose and want the highest evidence-backed ceiling, the injection has an advantage.

**You cannot reliably maintain the morning fasting window.** Shift workers, people with very early starts, parents of young children, and people whose mornings are genuinely unpredictable may find the 30-minute pre-food window difficult to manage consistently. The injection has no such requirement — you inject once a week on whatever day suits you, with no fasting rules.

**You prefer once-weekly to once-daily.** For some people, a weekly injection is genuinely easier to remember and to administer than a daily tablet. A once-weekly routine with a calendar reminder is simple and consistent. If you already struggle with daily medication adherence, the injection’s weekly schedule may actually suit you better.

**Your prescriber has recommended the injection for specific clinical reasons.** There are clinical situations where a prescriber may recommend one formulation over another based on your medical history, any concurrent conditions, or medications you are taking. Follow that guidance.

—

## The side-by-side comparison

| | **Wegovy injection** | **Wegovy tablet** |
|—|—|—|
| Starting UK price | ~£149–£269/month | From £64/month |
| Dosing schedule | Once weekly | Once daily |
| Max weight loss (clinical trials) | ~20.7% | ~14–16% |
| Fasting required | No | Yes — 30 min every morning |
| Refrigeration needed | Yes (2–8°C) | No |
| Needle required | Yes | No |
| Travel-friendly | Carry-on only, declared | Standard luggage, no declaration |
| GPhC-registered provider required | Yes | Yes |
| NHS availability (June 2026) | Very restricted | Not yet available |
| MHRA licensed for weight management | Yes | Yes |

—

## The honest section: what the evidence actually says

The injection produces better weight loss outcomes in the clinical trial data, on average, for most people. This is true, and it is worth stating clearly rather than softening it.

The reasons to choose the tablet — cost, needle-free, travel convenience, lifestyle fit — are all real and meaningful. But they are not weight loss effectiveness reasons. The tablet’s advantages are logistical and adherence-related, not pharmacological.

That said, a treatment you take consistently at a slightly lower effectiveness ceiling will produce better real-world results than a treatment you take inconsistently at a higher ceiling. Adherence is a clinical outcome. A 15% average weight loss in people who take the tablet daily for 18 months is more useful than a theoretical 20% in people who stop the injection after six months because the needle was always a barrier.

This is the honest trade-off. Know what you are choosing and why.

—

## What your prescriber will consider

A qualified prescriber will not simply ask which format you prefer and prescribe it. A thorough assessment will typically include:

– Your starting BMI and overall weight loss goal
– Your relevant medical history and any conditions that might affect which formulation is more appropriate
– Any medications you are currently taking (some medications may interact differently with the tablet vs injection)
– Your lifestyle and daily routine — including whether the morning fasting window is realistic for you
– Whether you have previous experience with GLP-1 treatment
– Your specific reasons for preferring one format over the other

The prescriber’s role is to give you a recommendation based on this full picture, not just your stated preference. A good assessment takes time. If your consultation feels rushed, it is worth asking whether there is time to discuss your options properly.

—

## Can you try one and switch to the other later?

Yes — but switching requires a new clinical assessment and a new prescription. You cannot simply move from one to the other. If you start with the tablet and decide later that the injection would suit you better (or vice versa), speak to your prescriber about what the switch would involve. See our dedicated switching guides for detail on what that process looks like.

—

## Frequently asked questions

### Can I try the Wegovy tablet and switch to the injection later if I want more weight loss?

Yes, switching between formulations is possible — but it requires a prescriber’s assessment and a new prescription. You should discuss this possibility with your prescriber at the outset so you have a clear picture of what switching would involve if your needs change.

### Is the Wegovy tablet new and relatively untested?

Oral semaglutide has been through substantial clinical trials (the OASIS programme), and the MHRA only approved it in June 2026 after a full regulatory review. It is a new product, but it is not an experimental one. The active ingredient — semaglutide — has been in clinical use for years via the injection. The oral delivery mechanism is what is new.

### Which is more convenient — injection or tablet?

This depends entirely on your lifestyle. Once-weekly injection is convenient for many people. Once-daily tablet is convenient for others. The tablet’s travel and storage advantages are real; the injection’s no-fasting-window advantage is also real. There is no objectively more convenient option — it depends on which inconveniences matter less to you.

### Will the Wegovy tablet work if I’ve tried the injection before?

If you have previously used the Wegovy injection (or any semaglutide product), your body has experience with the molecule. Individual response to the tablet is likely to be broadly similar to the injection in terms of how semaglutide works in your body, though the dose, absorption, and daily routine are different. Speak to your prescriber about your previous experience — it is relevant information for the assessment.

### Is the injection stronger than the tablet?

In clinical trial data, the injection produces higher average weight loss. Whether “stronger” is the right word depends on how you define it. The tablet delivers semaglutide at much higher doses (up to 25mg vs 2.4mg) to compensate for lower absorption — so the tablet dose numbers are not comparable to injection doses. Both work; the injection shows better outcomes on average in the evidence to date.

—

*This article is for informational purposes only and does not constitute medical advice. Wegovy tablets and Wegovy injection (oral and injectable semaglutide) are prescription-only medicines available in the UK. Always consult a registered UK healthcare professional before starting any weight management treatment, and follow the patient information leaflet supplied with your medication. CompareWegovyPrices.co.uk is not affiliated with Novo Nordisk.*